Sentiment Trading

Opthea Ltd, an Australian biotechnology company focused on treating eye disease, has remained largely silent in recent months, sparking concerns among investors and stakeholders about its progress and future prospects.

Opthea Limited, a biotechnology company, has announced a series of strategic decisions, including a settlement with investors and leadership changes, in response to the failure of its clinical trials for a wet AMD treatment.